Xingbo Cheng[Author] - Search Results

Year	Number of Results
2009	1
2010	2
2011	1
2012	2
2016	4
2017	5
2018	2
2019	7
2020	9
2021	16
2022	9
2023	9
2024	3

1

Multiple Natural Polymers in Drug and Gene Delivery Systems.

Jiang Z, Song Z, Cao C, Yan M, Liu Z, Cheng X, Wang H, Wang Q, Liu H, Chen S. Jiang Z, et al. Among authors: cheng x. Curr Med Chem. 2024;31(13):1691-1715. doi: 10.2174/0929867330666230316094540. Curr Med Chem. 2024. PMID: 36927424 Review.

2

ECM2, a prognostic biomarker for lower grade glioma, serves as a potential novel target for immunotherapy.

Cheng X, Liu Z, Liang W, Zhu Q, Wang C, Wang H, Zhang J, Li P, Gao Y. Cheng X, et al. Int J Biochem Cell Biol. 2023 May;158:106409. doi: 10.1016/j.biocel.2023.106409. Epub 2023 Mar 29. Int J Biochem Cell Biol. 2023. PMID: 36997057 Free article.

3

Prognostic significance of HSF2BP in lung adenocarcinoma.

Huang Z, Liu Z, Cheng X, Han Z, Li J, Xia T, Gao Y, Wei L. Huang Z, et al. Among authors: cheng x. Ann Transl Med. 2021 Oct;9(20):1559. doi: 10.21037/atm-21-4935. Ann Transl Med. 2021. PMID: 34790765 Free PMC article.

4

The association between expression of lncRNAs in patients with GDM.

Li Y, Li D, Cheng X. Li Y, et al. Among authors: cheng x. Endocr Connect. 2021 Sep 6;10(9):1080-1090. doi: 10.1530/EC-21-0227. Endocr Connect. 2021. PMID: 34289446 Free PMC article.

5

ITGB3BP is a potential biomarker associated with poor prognosis of glioma.

Liu Z, Liu B, Bian L, Wang H, Jia Y, Wang Y, Zhang W, Wang Y, Han Z, Cheng X, Lian X, Ren Z, Gao Y. Liu Z, et al. Among authors: cheng x. J Cell Mol Med. 2022 Feb;26(3):813-827. doi: 10.1111/jcmm.17127. Epub 2021 Dec 24. J Cell Mol Med. 2022. PMID: 34953037 Free PMC article.

6

Expression and clinical significance of TIMELESS in glioma.

Ren Z, Ma S, Cheng X, Guo Y, Liu Z. Ren Z, et al. Among authors: cheng x. Int J Clin Exp Pathol. 2021 Sep 15;14(9):938-955. eCollection 2021. Int J Clin Exp Pathol. 2021. PMID: 34646412 Free PMC article.

7

High expression of HOXA4 in patients with glioma indicates unfavorable clinical outcomes.

Yu Z, Liu Z, Lian X, Cheng X, Liu B, Zhang B, Wang H, Wang J, Li A, Ren Z, Pang B, Qian R, Gao Y. Yu Z, et al. Among authors: cheng x. Cell Cycle. 2022 Nov;21(22):2387-2402. doi: 10.1080/15384101.2022.2096715. Epub 2022 Jul 19. Cell Cycle. 2022. PMID: 35852388 Free PMC article.

8

GNG12 as A Novel Molecular Marker for the Diagnosis and Treatment of Glioma.

Liu R, Liu Z, Zhao Y, Cheng X, Liu B, Wang Y, Wang J, Lian X, Zhu Y, Gao Y. Liu R, et al. Among authors: cheng x. Front Oncol. 2022 Jul 19;12:726556. doi: 10.3389/fonc.2022.726556. eCollection 2022. Front Oncol. 2022. PMID: 35928884 Free PMC article.

9

Identification of PYGL as a key prognostic gene of glioma by integrated bioinformatics analysis.

Zhu Y, Liu Z, Lv D, Cheng X, Wang J, Liu B, Han Z, Wang Y, Liu R, Gao Y. Zhu Y, et al. Among authors: cheng x. Future Oncol. 2022 Feb;18(5):579-596. doi: 10.2217/fon-2021-0759. Epub 2022 Jan 17. Future Oncol. 2022. PMID: 35037470

10

DRAXIN as a Novel Diagnostic Marker to Predict the Poor Prognosis of Glioma Patients.

Jia Y, Liu Z, Cheng X, Liu R, Li P, Kong D, Liang W, Liu B, Wang H, Bu X, Gao Y. Jia Y, et al. Among authors: cheng x. J Mol Neurosci. 2022 Oct;72(10):2136-2149. doi: 10.1007/s12031-022-02054-2. Epub 2022 Aug 30. J Mol Neurosci. 2022. PMID: 36040678 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

66 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

66 results

Results by year